These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35715881)

  • 21. Pediatric Allergic Contact Dermatitis: Clinical and Epidemiological Study in a Tertiary Hospital.
    Ortiz Salvador JM; Esteve Martínez A; Subiabre Ferrer D; Victoria Martínez AM; de la Cuadra Oyanguren J; Zaragoza Ninet V
    Actas Dermosifiliogr; 2017; 108(6):571-578. PubMed ID: 28284423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic contact dermatitis due to the beta-blocker betaxolol in eyedrops, with cross-sensitivity to timolol.
    Nino M; Napolitano M; Scalvenzi M
    Contact Dermatitis; 2010 May; 62(5):319-20. PubMed ID: 20536484
    [No Abstract]   [Full Text] [Related]  

  • 23. Allergic Contact Dermatitis From Topical Drugs: An Overview.
    de Groot A
    Dermatitis; 2021 Jul-Aug 01; 32(4):197-213. PubMed ID: 34415695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic contact dermatitis due to timolol and levobunolol in eyedrops, with no cross-sensitivity to other ophthalmic beta-blockers.
    Koch P
    Contact Dermatitis; 1995 Aug; 33(2):140-1. PubMed ID: 8549145
    [No Abstract]   [Full Text] [Related]  

  • 25. Allergic contact dermatitis caused by topical herbal remedies: importance of patch testing with the patients' own products.
    Gilissen L; Huygens S; Goossens A
    Contact Dermatitis; 2018 Mar; 78(3):177-184. PubMed ID: 29214642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical ophthalmic agents as allergens in periorbital dermatitis.
    Landeck L; John SM; Geier J
    Br J Ophthalmol; 2014 Feb; 98(2):259-62. PubMed ID: 24276696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difficulties in the interpretation of patch test reactions to ophthalmic beta-blockers.
    Carrière M; Giordano-Labadie F; Schwarze HP; Loche F; Bazex J
    Contact Dermatitis; 1998 Dec; 39(6):319-20. PubMed ID: 9874031
    [No Abstract]   [Full Text] [Related]  

  • 28. Allergic contact dermatitis in children: the Ottawa hospital patch-testing clinic experience, 1996 to 2006.
    Hogeling M; Pratt M
    Dermatitis; 2008; 19(2):86-9. PubMed ID: 18413109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications.
    Nishioka K; Koizumi A; Takita Y
    J Dermatol; 2022 May; 49(5):515-518. PubMed ID: 35174533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. North American Contact Dermatitis Group Patch Test Results: 2017-2018.
    DeKoven JG; Silverberg JI; Warshaw EM; Atwater AR; Reeder MJ; Sasseville D; Taylor JS; Zug KA; Belsito DV; Maibach HI; Pratt MD; Cgt M; DeLeo VA; Fowler JF
    Dermatitis; 2021 Mar-Apr 01; 32(2):111-123. PubMed ID: 33970567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group.
    Hillen U; Jappe U; Frosch PJ; Becker D; Brasch J; Lilie M; Fuchs T; Kreft B; Pirker C; Geier J;
    Br J Dermatol; 2006 Apr; 154(4):665-70. PubMed ID: 16536809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periorbital contact sensitization.
    Landeck L; Schalock PC; Baden LA; Gonzalez E
    Am J Ophthalmol; 2010 Sep; 150(3):366-370.e2. PubMed ID: 20541737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergic axillary dermatitis due to hydrogenated castor oil in a deodorant.
    Taghipour K; Tatnall F; Orton D
    Contact Dermatitis; 2008 Mar; 58(3):168-9. PubMed ID: 18279156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens.
    Marks JG; Belsito DV; DeLeo VA; Fowler JF; Fransway AF; Maibach HI; Mathias CG; Nethercott JR; Rietschel RL; Sherertz EF; Storrs FJ; Taylor JS
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):911-8. PubMed ID: 9631997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience.
    Taylor JS; Praditsuwan P; Handel D; Kuffner G
    Arch Dermatol; 1996 May; 132(5):515-8. PubMed ID: 8624147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Path test reactions to the Chinese Standard Screening Allergens in 1,135 patients investigated for allergic contact dermatitis.
    Liu YQ; Zhao B; Zhuang LH; Fan WX
    Am J Contact Dermat; 1997 Sep; 8(3):141-3. PubMed ID: 9249281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contact dermatitis to topical medicaments: a retrospective chart review from the Ottawa Hospital Patch Test Clinic.
    Spring S; Pratt M; Chaplin A
    Dermatitis; 2012; 23(5):210-3. PubMed ID: 23010827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contact allergic reactions of the vulva: a 14-year review.
    Nardelli A; Degreef H; Goossens A
    Dermatitis; 2004 Sep; 15(3):131-6. PubMed ID: 15724347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of previously patch-tested patients referred to a contact dermatitis clinic.
    Soni BP; Sherertz EF
    Am J Contact Dermat; 1997 Mar; 8(1):10-4. PubMed ID: 9066841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic contact dermatitis to chlorhexidine-containing antiseptics and their excipients in children: A series of six cases.
    Kefala K; Ponvert C
    Pediatr Dermatol; 2023 Jan; 40(1):151-153. PubMed ID: 36511886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.